Literature DB >> 21395639

Drug-drug interactions--bridging the gulf between the bench and the bedside?

Y K Loke.   

Abstract

Mesh：

Year:  2011        PMID： 21395639      PMCID： PMC3080633          DOI： 10.1111/j.1365-2125.2011.03951.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.

Authors:  Subhash Banerjee; Rick A Weideman; Mark W Weideman; Bertis B Little; Kevin C Kelly; Jennifer T Gunter; Kathryn L Tortorice; Michelle Shank; Byron Cryer; Robert F Reilly; Sunil V Rao; Adnan Kastrati; James A de Lemos; Emmanouil S Brilakis; Deepak L Bhatt
Journal:  Am J Cardiol       Date:  2011-01-19       Impact factor: 2.778

2.  Extreme bradycardia due to multiple drug-drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir-ritonavir.

Authors:  Rachel Puech; Marie-Claude Gagnieu; Caroline Planus; Bruno Charpiat; André Boibieux; Tristan Ferry; Michel Tod
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

3.  Paraoxonase-1 is a major determinant of clopidogrel efficacy.

Authors:  Heleen J Bouman; Edgar Schömig; Jochem W van Werkum; Janna Velder; Christian M Hackeng; Christoph Hirschhäuser; Christopher Waldmann; Hans-Günther Schmalz; Jurriën M ten Berg; Dirk Taubert
Journal:  Nat Med       Date:  2010-12-19       Impact factor: 53.440

4.  In silico prediction of efavirenz and rifampicin drug-drug interaction considering weight and CYP2B6 phenotype.

Authors:  Dinko Rekić; Daniel Röshammar; Jackson Mukonzo; Michael Ashton
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

5.  Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity.

Authors:  Renata Monteiro Lima; Maria Augusta Drago Ferreira; Teresa Maria de Jesus Ponte Carvalho; Bruno José Dumêt Fernandes; Osvaldo Massaiti Takayanagui; Hector Hugo Garcia; Eduardo Barbosa Coelho; Vera Lucia Lanchote
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

6.  Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects.

Authors:  Richat Abbas; Bruce A Hug; Cathie Leister; Jaime Burns; Daryl Sonnichsen
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

7.  The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine.

Authors:  Tore Haslemo; Helge Refsum; Espen Molden
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

8.  Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: a population-based study.

Authors:  Tony Antoniou; Tara Gomes; Muhammad M Mamdani; David N Juurlink
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

9.  Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.

Authors:  Dirk Sibbing; Tanja Morath; Julia Stegherr; Siegmund Braun; Wolfgang Vogt; Martin Hadamitzky; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

Review 10.  Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.

Authors:  C S Kwok; Y K Loke
Journal:  Aliment Pharmacol Ther       Date:  2010-01-22       Impact factor: 8.171
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.